Antihypertensive drug use and psoriasis: A systematic review, meta- and network meta-analysis.

Published on Oct 5, 2021in British Journal of Clinical Pharmacology4.34
路 DOI :10.1111/BCP.15060
Gonjin Song2
Estimated H-index: 2
(Ewha Womans University),
Ha Young Yoon4
Estimated H-index: 4
(Ewha Womans University)
+ 2 AuthorsHye Sun Gwak17
Estimated H-index: 17
(Ewha Womans University)
Sources
Abstract
AIMS: Diverse genetic and/or external factors may induce psoriasis. Drug exposure is 1 such prominent external factor; antihypertensive drugs are reportedly associated with psoriasis, but study results have been inconsistent. In this context, we investigated the associations between antihypertensive drugs and incidence if psoriasis via a systematic literature review and meta-analysis. METHODS: Literature search in databases such as PubMed, Embase and Web of Science was conducted on 8 January 2021, and obtained data were pooled for meta- and network meta-analysis. Fixed- or random effect models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for evaluating the strength of the associations between antihypertensive drugs and psoriasis incidence. In addition to meta-analysis, Bayesian network meta-analysis was performed. ResultsThirteen eligible studies were included for meta-analysis with 6 378 116 individuals and 8 studies for network meta-analysis with 5 615 918 individuals. All antihypertensive drugs were significantly associated with psoriasis incidence. In a meta-analysis, the pooled ORs were 1.67 (95% CI: 1.31-2.13) for angiotensin-converting enzyme (ACE) inhibitors, 1.40 (95% CI: 1.20-1.63) for s-blockers, 1.53 (95% CI: 1.23-1.89) for calcium-channel blockers (CCBs), and 1.70 (95% CI: 1.40-2.06) for thiazide diuretics. For the comparative risks of psoriasis among antihypertensive drugs in the network meta-analysis, ORs were 2.09 (95% CI: 1.39-3.18) for ACE inhibitors, 1.35 (95% CI: 0.99-1.91) for BBs, 1.53 (95% CI: 1.07-2.24) for CCBs and 1.80 (95% CI: 1.23-2.66) for thiazide diuretics. CONCLUSION: This study confirmed the associations between antihypertensive drugs and psoriasis; ACE inhibitors, BBs, CCBs and thiazide diuretics increased the risk of psoriasis. Therefore, antihypertensive drug users should be carefully monitored for psoriasis.
馃摉 Papers frequently viewed together
2001
1 Author (Stephen MacMahon)
20185.61Drug Safety
5 Authors (Huilin Tang, ..., Jiali Han)
6 Authors (Lu Ren, ..., Phung N. Thai)
References59
Newest
#1Brahim Azzouz (URCA: University of Reims Champagne-Ardenne)H-Index: 3
Last. Thierry Trenque (URCA: University of Reims Champagne-Ardenne)H-Index: 14
view all 7 authors...
Summary Introduction: Evidence regarding a possible association between psoriatic manifestations and use of calcium channel blockers (CCBs) is sparse. Currently, psoriatic manifestations are not listed in the summary of product characteristics (SmPC) of CCBs. In this context, we aimed to investigate the association between psoriasis and CCB exposure. Methods: We reviewed spontaneous reports recorded in the French national Pharmacovigilance Database (FPVD) between 1985 and 2019. The association b...
Source
Background and objectives Keratinocyte cancers, which primarily comprise squamous cell carcinomas and basal cell carcinomas, represent a major concern and potential risk for kidney transplant recipients. Hydrochlorothiazide, a diuretic widely used to treat hypertension, has been implicated in skin photosensitivity reaction. Recent studies conducted in the general population have found that hydrochlorothiazide use is associated with a higher risk of keratinocyte cancer, especially squamous cell c...
Source
#1Albert Duvetorp (Link枚ping University)H-Index: 5
#2Ulrich MrowietzH-Index: 80
Last. Oliver Seifert (Link枚ping University)H-Index: 11
view all 4 authors...
A large body of evidence supports the association between psoriasis and concomitant diseases. However, the study of comedication for these diseases in patients with psoriasis is limited. The current study aimed to investigate the prescription and drug dispensation for comorbidity associated with psoriasis. We conducted a retrospective case-control study from 9 April 2008 until 1 January 2016 using an electronic medical records database covering the entire population of the County of Jonkoping an...
Source
#1Rosa Parisi (University of Manchester)H-Index: 12
#2I Y K Iskandar (University of Manchester)H-Index: 7
Last. Darren M. Ashcroft (University of Manchester)H-Index: 65
view all 6 authors...
Abstract Objective To systematically review and provide information on the incidence of psoriasis and quantify global, regional, and country specific estimates of its prevalence. Design Systematic review and meta-analysis. Data sources Medline, Embase, Web of Science, SciELO, Korean Journal Databases, Russian Science Citation Index, WPRIM, SaudiMedLit, Informit, IndMed, and HERDIN were searched systematically from their inception dates to October 2019. Methods Studies were included if they repor...
Source
#1Danilo Baccino (UniGe: University of Genoa)H-Index: 2
#2Giulia Merlo (UniGe: University of Genoa)H-Index: 7
Last. Aurora Parodi (UniGe: University of Genoa)H-Index: 35
view all 7 authors...
INTRODUCTION: Treatment with antihypertensive drugs may be associated with different dermatological adverse reactions. EVIDENCE ACQUISITION: We systematically reviewed the literature available on the MEDLINE (PubMED) databases, up to July 2018. We searched for the terms "calcium-channel blockers" or "angiotensin-converting enzyme inhibitors" or "angiotensin II receptors blockers" or "diuretics" or "beta blockers" AND "dermatological effects" or "skin disease". EVIDENCE SYNTHESIS: The most import...
Source
#1Xi DuanH-Index: 3
#2Junbo Liu (North Sichuan Medical College)H-Index: 3
Last. Tao Wu (North Sichuan Medical College)H-Index: 5
view all 8 authors...
BACKGROUND: Several studies have shown a relationship between psoriasis and hypertension, but no meta-analysis has been restricted to studies that adjusted for confounders. The aim of the study was to estimate the association between psoriasis and hypertension with adjustment for covariates. METHODS: A systematic literature search in the MEDLINE, Embase, Cochrane databases, and Google Scholar was conducted to identify relevant studies which reported the association of psoriasis with the risk of ...
Source
: 尾-Blockers are a widely utilised class of medication. They have been in use for a variety of systemic disorders including hypertension, heart failure and intention tremors. Their use in dermatology has garnered growing interest with the discovery of their therapeutic effects in the treatment of haemangiomas, their potential positive effects in wound healing, Kaposi sarcoma, melanoma and pyogenic granuloma, and, more recently, pemphigus. Since 尾-blockers are deployed in a variety of disorders, ...
Source
#1Jui-Ming Liu (South Korean Ministry for Health, Welfare and Family Affairs)H-Index: 15
#2Chien-Yu Lin (Mackay Memorial Hospital)H-Index: 16
Last. Ren-Jun Hsu (NDMC: National Defense Medical Center)H-Index: 18
view all 4 authors...
Objective: Androgen deprivation therapy (ADT) use in prostate cancer (PCa) patients has been reported to exacerbate the course of psoriasis. We aimed to assess the impact of ADT on the subsequent risk of psoriasis. Methods: We utilized data from the National Health Insurance Research Database of Taiwan between 1996 and 2013. In total, 17,168 patients with PCa were identified; 5,141 ADT patients comprised the study group with 5,141 matched non-ADT controls. We used 1:1 propensity score-matched an...
Source
#1Bryan WilliamsH-Index: 8
#2G. ManciaH-Index: 22
Last. A DominiczakH-Index: 3
view all 28 authors...
Source
#1Ha-Na Kim (Catholic University of Korea)H-Index: 12
#2Kyungdo Han (Catholic University of Korea)H-Index: 40
Last. Ji Hyun Lee (Catholic University of Korea)H-Index: 24
view all 4 authors...
Psoriasis is a chronic inflammatory skin disease that is characterized by T-cell mediated immune response, and has been known to increase the risk of developing hypertension. However, the risk of psoriasis in patients with hypertension is not clear. Therefore, we investigated the risk of psoriasis in patients with hypertension. A total of 256,356 adults (42,726 in the hypertension group and 213,630 in the control group) were followed from 2003 to 2013 in a nationwide population-based cohort stud...
Source
Cited By0
Newest
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.